End-to-end formulation development and quality establishment service for live biotherapeutic products. Supports pre-clinical and early-clinical CMC development with a focus on viability, stability, potency, manufacturability and IND-enabling quality strategy.
Key Points:
- Formulation optimization for live biotherapeutics;
- Quality strategy aligned with CMC development;
- Manufacturability and process feasibility support;
- Suitable for preclinical and early clinical programs
